Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants

BACKGROUND AND AIMS: ROTAVAC® (frozen formulation stored at −20 °C) and ROTAVAC 5D® (liquid formulation stable at 2–8 °C) are rotavirus vaccines derived from the 116E human neonatal rotavirus strain, developed and licensed in India. This study evaluated and compared the safety and immunogenicity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilengi, R., Mwila- Kazimbaya, K., Chirwa, M., Sukwa, N., Chipeta, C., Velu, R.M., Katanekwa, N., Babji, S., Kang, G., McNeal, M.M., Meyer, N., Gompana, G., Hazra, S., Tang, Y., Flores, J., Bhat, N., Rathi, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204902/
https://www.ncbi.nlm.nih.gov/pubmed/33992437
http://dx.doi.org/10.1016/j.vaccine.2021.04.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204902/
https://www.ncbi.nlm.nih.gov/pubmed/33992437
http://dx.doi.org/10.1016/j.vaccine.2021.04.060

Ejemplares similares